Publications by authors named "Biswajit Naik"

Claim this Profile
T
Targeting Plasmodium falciparum Single-Stranded DNA-Binding Protein: Discovery of New Scaffold Compounds Effective against Drug-Sensitive and Artemisinin-Resistant Strains.
Biswajit Naik, Preshita Bhalerao, Shashank Shekhar, Stephy A Varghese, Sweta Makwana

ChemMedChem· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-based virtual screening against multiple Plasmodium falciparum kinases reveals antimalarial compounds.
Priya Godara, K Sony Reddy, Welka Sahu, Biswajit Naik, Varshita Srivastava

Mol Divers· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-based virtual screening approach reveals natural multi-target compounds for the development of antimalarial drugs to combat drug resistance.
Biswajit Naik, Nidhi Gupta, Priya Godara, Varshita Srivastava, Prateek Kumar

J Biomol Struct Dyn· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of FDA-approved drugs with triple targeting mode of action for the treatment of monkeypox: a high throughput virtual screening study.
Varshita Srivastava, Biswajit Naik, Priya Godara, Dorothy Das, Venkata Satish Kumar Mattaparthi

Mol Divers· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptide-ligand conjugate based immunotherapeutic approach for targeted dismissal of non-structural protein 1 of dengue virus: A novel therapeutic solution for mild and severe dengue infections.
Varshita Srivastava, Priya Godara, Sudip Prasad Jena, Biswajit Naik, Satyendra Singh

Int J Biol Macromol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemical system biology approach to identify multi-targeting FDA inhibitors for treating COVID-19 and associated health complications.
Biswajit Naik, Venkata Satish Kumar Mattaparthi, Nidhi Gupta, Rupal Ojha, Pundarikaksha Das

J Biomol Struct Dyn· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rational designing of peptide-ligand conjugates-based immunotherapy for the treatment of complicated malaria.
Priya Godara, Biswajit Naik, Rajshree Meghwal, Rupal Ojha, Varshita Srivastava

Life Sci· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of antiviral peptide inhibitors for receptor binding domain of SARS-CoV-2 omicron and its sub-variants: an in-silico approach.
Swati Singh, Hemanth Naick Banavath, Priya Godara, Biswajit Naik, Varshita Srivastava

3 Biotech· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asymptomatic malaria infection prevailing risks for human health and malaria elimination.
Dhaneswar Prusty, Nidhi Gupta, Arun Upadhyay, Ashraf Dar, Biswajit Naik

Infect Genet Evol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment.
Biswajit Naik, Nidhi Gupta, Rupal Ojha, Satyendra Singh, Vijay Kumar Prajapati

Int J Biol Macromol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High throughput and comprehensive approach to develop multiepitope vaccine against minacious COVID-19.
Rupal Ojha, Nidhi Gupta, Biswajit Naik, Satyendra Singh, Vijay Kumar Verma

Eur J Pharm Sci· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis